Influence of Restitution Time in Treatment of Patellar Tendinopathy (NCT05731037) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Influence of Restitution Time in Treatment of Patellar Tendinopathy
Denmark52 participantsStarted 2023-03-02
Plain-language summary
The purpose of the present project is to investigate if the restitution time from loading in an exercise-based 12 weeks rehabilitation regime for patellar tendinopathy influences the clinical outcome, tendon structure and function.
The investigators hypothesize that greater restitution from loading (1 exercise day per week) will yield a greater positive clinical outcome, and tissue structure and function in patients with patellar tendinopathy compared to less restitution (3 exercise days per week), when impact activities are restricted in both groups.
Who can participate
Age range
18 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Sports active men and women.
* Age (18-60) years old.
* BMI (18.5-30)
* Understand and read Danish
* Uni- or bilateral patellar tendinopathy
* Symptom onset \>90 days ago
Exclusion Criteria:
* Patellar tendinopathy longer than 24 months
* Smoking
* Previous surgery in the knee on the ipsilateral side.
* Corticosteroid injection in the patellar tendon on the ipsilateral side within the last 6 months.
* Any confounding diagnosis to the knee joint
* Known arthritis
* Known diabetes
* Inability to follow rehabilitation or complete follow-ups
* Enrolled in a resistance based-rehabilitation program for the affected patellar tendon within the previous three month
* Have a work were it is not feasible to avoid pain provoking tasks
Extra criteria sub-study one
Inclusion criteria:
• Five patients from the main study, rating "improved" and "not improved" respectively, will be invited to participate in sub-study one.
Exclusion criteria:
* Claustrophobia
* Pregnancy
* Breastfeeding
Extra criteria sub-study two:
Inclusion criteria:
* Patients from the main study, that rate themselves 'not improved' in symptoms after 12 week.
* Patients who have not achieved Patient Acceptable Symptom State (PASS) after week 20, 24, 28, 32, 36 and 40, will be invited to participate in sub- study two.
Exclusion criteria:
* Pregnancy
* Breastfeeding
* Previously had an allergic reaction for steroid (Depomedrol).
* Previously had an allergic reaction for local anesthesia trea…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.